Quick Answer
Aura Biosciences, Inc. reported Total Assets of $169.43 million for the year ending 2025.
- Aura Biosciences, Inc. showed a decrease of -7.2% in Total Assets from 2024 to 2025.
- This data is from Aura Biosciences, Inc.'s annual report (Form 10-K), filed with the SEC on March 30, 2026.
- XBRL data for this metric is available from 2020 to 2025 (6 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q3 2021: $90.70 million | Q1 2022: $146.42 million | Q2 2022: $135.02 million | Q3 2022: $143.15 million | Q1 2023: $206.02 million | Q2 2023: $192.74 million | Q3 2023: $179.77 million | Q1 2024: $235.03 million | Q2 2024: $218.28 million | Q3 2024: $205.34 million | Q1 2025: $155.40 million | Q2 2025: $204.40 million | Q3 2025: $190.02 million.
- Over the full 6 years of available data (2020 to 2025), Aura Biosciences, Inc.'s Total Assets has grown by 666.5%.
- Historical annual values: Fiscal year 2025: $169.43 million | Fiscal year 2024: $182.50 million | Fiscal year 2023: $255.08 million | Fiscal year 2022: $223.94 million | Fiscal year 2021: $160.03 million | Fiscal year 2020: $22.10 million.
- Data sourced from SEC EDGAR public filings as of August 6, 2026.
Last verified: